171 related articles for article (PubMed ID: 32621880)
1. Oral administration of natural polyphenol-loaded natural polysaccharide-cloaked lipidic nanocarriers to improve efficacy against small-cell lung cancer.
Xie X; Li Y; Zhao D; Fang C; He D; Yang Q; Yang L; Chen R; Tan Q; Zhang J
Nanomedicine; 2020 Oct; 29():102261. PubMed ID: 32621880
[TBL] [Abstract][Full Text] [Related]
2. Natural Oral Anticancer Medication in Small Ethanol Nanosomes Coated with a Natural Alkaline Polysaccharide.
Zhao J; Li Y; He D; Hu X; Li K; Yang Q; Fang C; Zhong C; Yang J; Tan Q; Zhang J
ACS Appl Mater Interfaces; 2020 Apr; 12(14):16159-16167. PubMed ID: 32186843
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease.
Beloqui A; Memvanga PB; Coco R; Reimondez-Troitiño S; Alhouayek M; Muccioli GG; Alonso MJ; Csaba N; de la Fuente M; Préat V
Colloids Surf B Biointerfaces; 2016 Jul; 143():327-335. PubMed ID: 27022873
[TBL] [Abstract][Full Text] [Related]
4. Composite alkali polysaccharide supramolecular nanovesicles improve biocharacteristics and anti-lung cancer activity of natural phenolic drugs via oral administration.
Huang Y; Hu X; Zhao H; He D; Li Y; Yang M; Yu Z; Li K; Zhang J
Int J Pharm; 2020 Jan; 573():118864. PubMed ID: 31765782
[TBL] [Abstract][Full Text] [Related]
5. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs.
Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J
Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270
[TBL] [Abstract][Full Text] [Related]
6. Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material.
Li W; Zhang T; Ye Y; Zhang X; Wu B
Int J Pharm; 2015 Nov; 495(2):948-55. PubMed ID: 26453780
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.
Zhang Z; Gao F; Bu H; Xiao J; Li Y
Nanomedicine; 2012 Jul; 8(5):740-7. PubMed ID: 21930110
[TBL] [Abstract][Full Text] [Related]
10. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
[TBL] [Abstract][Full Text] [Related]
11. Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin.
Li S; Fang C; Zhang J; Liu B; Wei Z; Fan X; Sui Z; Tan Q
Nanomedicine; 2016 Aug; 12(6):1567-79. PubMed ID: 26995093
[TBL] [Abstract][Full Text] [Related]
12. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
14. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
15. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
16. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
Davatgaran-Taghipour Y; Masoomzadeh S; Farzaei MH; Bahramsoltani R; Karimi-Soureh Z; Rahimi R; Abdollahi M
Int J Nanomedicine; 2017; 12():2689-2702. PubMed ID: 28435252
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
18. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
Li J; Jiang F; Chi Z; Han D; Yu L; Liu C
Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.
Bondì ML; Emma MR; Botto C; Augello G; Azzolina A; Di Gaudio F; Craparo EF; Cavallaro G; Bachvarov D; Cervello M
J Agric Food Chem; 2017 Feb; 65(7):1342-1352. PubMed ID: 28111949
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
